Menú Close

Artículos sobre Vaccines

Mostrando 61 - 80 de 558 artículos

At the end of 2020, India applied to the WTO for a temporary suspension of intellectual property rights related to Covid-19. Sanjay Kanojia/AFP

Intellectual property and Covid-19: how can we accelerate vaccination globally?

Licensing agreements between pharmaceutical companies and the Medicines Patent Pool, in cooperation with the WHO, could accelerate access to doses for the poorest countries.
Parents may find it challenging to get their children comfortable going back out into the world. Paul Bersebach/Orange County Register via Getty Images

America goes back to school – 5 essential reads on parenting in the pandemic

As more people get vaccinated and different facets of society slowly reopen, challenges remain in the nation’s quest to get back to normal. Here are five articles that help illuminate the path.
Workers pack syringes at India’s biggest syringe manufacturer. Government support has been key to developing this capacity. Photo by Sajjad Hussain/AFP via Getty Images

South African case study sheds light on how vaccine manufacturing can be developed

African governments, firms and donor agencies should align their efforts to support the local manufacture of vaccines and other health equipment in African countries.
A healthcare worker administers an Oxford/AstraZeneca COVID-19 vaccine to her colleague at Mutuini Hospital in Nairobi. Kenya on March 3, 2021. Photo by Dennis Sigwe/SOPA Images/LightRocket via Getty Images

Kenya’s COVID-19 vaccine rollout has got off to a slow start: the gaps, and how to fix them

Kenya grapples with two major challenges in the vaccination rollout: access to sufficient doses in light of the global shortage; and vaccine hesitancy.

Principales colaboradores

Más